| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/02/2000 | US6057318 Heterocyclic derivatives, process for their preparation and their therapeutic use |
| 05/02/2000 | US6057295 Oligopeptides derived from C-reactive protein fragments |
| 05/02/2000 | US6057294 Peptide |
| 05/02/2000 | US6057287 Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| 05/02/2000 | US6057131 Preparation and use of sialylated glycoforms of soluble complement receptor 1 (CR1) |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | US6056944 Pharmaceutical compositions for oral use including an NSAID and ceramides |
| 05/02/2000 | US6055936 Sea cucumber carotenoid lipid fractions and process |
| 05/02/2000 | CA2069961C Method and compositions for inhibition of disorders associated with oxidative damage |
| 05/02/2000 | CA2022740C Cyclic neurokinin a antagonists |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023471A2 Use of a cytokine-producing lactococcus strain to treat colitis |
| 04/27/2000 | WO2000023457A1 Adenine derivatives |
| 04/27/2000 | WO2000023439A1 Vitreous form of known bradykinin antagonist |
| 04/27/2000 | WO2000023438A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists |
| 04/27/2000 | WO2000023433A1 Substituted benzopyran analogs for the treatment of inflammation |
| 04/27/2000 | WO2000023430A1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 04/27/2000 | WO2000023426A1 Novel imidazoles with anti-inflammatory activity |
| 04/27/2000 | WO2000023421A1 (SUBSTITUTED)ACYL DIPEPTIDYL INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/27/2000 | WO2000023419A1 Novel prodrugs of non-steroidal anti-inflammatory carboxylic acids, their preparation and use |
| 04/27/2000 | WO2000023407A2 Ureido-thiobutyric acid derivatives as ppar-agonists |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023092A1 Contulakin-g, analogs thereof and uses therefor |
| 04/27/2000 | WO2000023091A2 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
| 04/27/2000 | WO2000023078A1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds |
| 04/27/2000 | WO2000023072A1 Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation |
| 04/27/2000 | WO2000023051A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | WO2000006137A3 Glucocorticoid-selective anti-inflammatory agents |
| 04/27/2000 | WO2000005265A3 Anti-crr2 antibodies and methods of use therefor |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | CA2347910A1 Substituted benzopyran analogs for the treatment of inflammation |
| 04/27/2000 | CA2347792A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/27/2000 | CA2347108A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2347001A1 Vitreous form of known bradykinin antagonist |
| 04/27/2000 | CA2346937A1 Specific therapeutic interventions obtained by interference with redistribution and/or targeting |
| 04/27/2000 | CA2346436A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists |
| 04/27/2000 | CA2346325A1 Bioflavonoids as plasma high density lipoprotein level increasing agent |
| 04/26/2000 | EP0995757A2 Bivalent inhibitors of the proteasome |
| 04/26/2000 | EP0995747A1 Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| 04/26/2000 | EP0995446A2 Antithrombin III-beta containing medical preparation |
| 04/26/2000 | EP0994903A1 Methods and compositions for galactosylated glycoproteins |
| 04/26/2000 | EP0994895A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/26/2000 | EP0994880A1 Crystalline macrolides and process for their preparation |
| 04/26/2000 | EP0994876A1 Quaternary ammonium compounds as tachykinin antagonists |
| 04/26/2000 | EP0994870A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 04/26/2000 | EP0994867A1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine |
| 04/26/2000 | EP0994860A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 04/26/2000 | EP0994858A1 2-substituted imidazoles useful in the treatment of inflammatory diseases |
| 04/26/2000 | EP0994853A2 Compounds and methods for the inhibition of the expression of vcam-1 |
| 04/26/2000 | EP0994719A1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
| 04/26/2000 | EP0994717A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 04/26/2000 | EP0994712A1 Inhibitors of neutrophil mediated oxidant production |
| 04/26/2000 | EP0994704A1 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases |
| 04/26/2000 | EP0670826B1 Fatty acid derivatives and pharmaceutical compositions containing them |
| 04/26/2000 | CN1251587A Pyrrolidine derivatives having phospholipase A inhibitory activity |
| 04/26/2000 | CN1251579A Compound and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| 04/26/2000 | CN1251522A Antirheumatic agents |
| 04/26/2000 | CN1251295A External-use bathing lotion with antibiotic and anti-inflammatory functions |
| 04/25/2000 | US6054599 Phytosphingosine-based ceramide I analogs |
| 04/25/2000 | US6054593 Elastase inhibitor |
| 04/25/2000 | US6054588 Heterocyclic vinyl ethers |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054559 Interleukin-1 receptor antagonist beta (IL-1raβ) |
| 04/25/2000 | US6054470 Src family SH2 domain inhibitors |
| 04/25/2000 | US6054143 Xylitol delivery |
| 04/20/2000 | WO2000022439A2 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022121A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 04/20/2000 | WO2000022113A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 04/20/2000 | WO2000021996A2 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | WO2000021995A1 Treatment of inflammatory disease |
| 04/20/2000 | WO2000021988A2 Human ankyrin family protein |
| 04/20/2000 | WO2000021979A2 Cyclic tetrapeptide and their use as histone deacetylase inhibitor |
| 04/20/2000 | WO2000021964A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and anfiinflammatory activity |
| 04/20/2000 | WO2000021963A1 Il-8 receptor antagonists |
| 04/20/2000 | WO2000021961A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | WO2000021959A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/20/2000 | WO2000021955A1 Quinazoline derivatives |
| 04/20/2000 | WO2000021947A1 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 04/20/2000 | WO2000021920A1 Diaminopropionic acid derivatives |
| 04/20/2000 | WO2000021557A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | WO2000021532A1 Methods for inhibiting bone resorption |
| 04/20/2000 | WO2000021530A1 Peripherally acting anti-pruritic opiates |
| 04/20/2000 | WO2000021525A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/20/2000 | WO2000021523A1 Methods for regulating bone formation |
| 04/20/2000 | WO2000021520A2 Opioid analgesic |
| 04/20/2000 | WO2000005245A3 Inhibitors of urokinase and blood vessel formation |
| 04/20/2000 | WO2000002519A3 Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain |
| 04/20/2000 | WO1999066065A3 Proteasomal activity |
| 04/20/2000 | WO1999066037A3 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |
| 04/20/2000 | WO1999048868A9 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 04/20/2000 | DE19847823A1 New 3-(Hetero)aryl-5-aminosulfonyl-1,2,4-thiadiazole derivatives useful as inhibitors of IL-1beta production in treatment of e.g. leukemia, septic shock, hepatitis, AIDS and diseases of locomotor system |
| 04/20/2000 | DE19847690A1 Diagnosing sepsis and severe infections, useful for assessing severity and progress of treatment, by measuring content of peptide prohormone or their derived fragments |
| 04/20/2000 | DE19844111A1 Novel antisense nucleic acids targeted to specific sequences within the ICAM-1 gene, useful for treating inflammation and metastasis |
| 04/20/2000 | CA2347653A1 Novel cell signaling polypeptides and nucleic acids |